Clinical • PD(L)-1 Biomarker • IO biomarker
|
PD-L1 (Programmed death ligand 1) • CD20 (Membrane Spanning 4-Domains A1)
|
PD-L1 expression • CD19 positive
|
Opdivo (nivolumab) • dasatinib • Rituxan (rituximab) • cyclophosphamide • Besponsa (inotuzumab ozogamicin) • fludarabine IV • varnimcabtagene autoleucel (ARI-0001)